Trailblazing tech for retinal imaging: DMEI residents share insights and advice for innovators (part 3)
Oct 28, 10:00 PM
In this third of an exclusive three-part Ophthalmology Times EyePod podcast series on innovation, we continue our discussion with Jibran Sharieff, MD, and Brandon Kingrey, MD, who are residents at the Dean McGee Eye Institute (DMEI) in Oklahoma City, Oklahoma. They recently won second place at the Eyecelerator competition held before this fall’s American Academy of Ophthalmology conference in Chicago, receiving a $15,000 prize—the first such prize awarded to residents—for their development of a smartphone device designed to take fundus images. This innovative tool aims to advance ophthalmic imaging accessibility. Join us as Sharieff and Kingrey share their future outlook for their smartphone device and advice for other young innovators.
Currently designed for undilated pupils, they aim to broaden the field of view and make the device compatible with various smartphones, including Samsung models. Plans include partnering with established manufacturers for FDA approval and exploring AI integration for enhanced analysis capabilities. They envision the device being used not only by ophthalmologists but also by ER doctors, primary care physicians, and neurologists, making optic nerve examination more accessible. Clinical trials with the Dean McGee Eye Institute are under way to validate its use.
For fellow residents and young ophthalmologists, the innovators advise finding small, impactful problems to solve and embracing iterative, hands-on experimentation. They stress the importance of simple, practical solutions in innovation, balancing clinical responsibilities with project work by choosing tasks that feel enjoyable rather than burdensome.
Currently designed for undilated pupils, they aim to broaden the field of view and make the device compatible with various smartphones, including Samsung models. Plans include partnering with established manufacturers for FDA approval and exploring AI integration for enhanced analysis capabilities. They envision the device being used not only by ophthalmologists but also by ER doctors, primary care physicians, and neurologists, making optic nerve examination more accessible. Clinical trials with the Dean McGee Eye Institute are under way to validate its use.
For fellow residents and young ophthalmologists, the innovators advise finding small, impactful problems to solve and embracing iterative, hands-on experimentation. They stress the importance of simple, practical solutions in innovation, balancing clinical responsibilities with project work by choosing tasks that feel enjoyable rather than burdensome.